• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有意识障碍的抗N-甲基-D-天冬氨酸受体脑炎患者的危险因素及预后

Risk Factors and Prognosis in Anti-NMDA Receptor Encephalitis Patients with Disturbance of Consciousness.

作者信息

Gong Zhuowei, Lao Dayuan, Huang Fang, Lv Sirao, Mao Fengping, Huang Wen

机构信息

Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.

出版信息

Patient Relat Outcome Meas. 2023 Jun 14;14:181-192. doi: 10.2147/PROM.S411260. eCollection 2023.

DOI:10.2147/PROM.S411260
PMID:37337520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10277025/
Abstract

PURPOSE

Disturbance of consciousness is common in patients with severe anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. However, little is known about it. This study aimed to analyze the clinical manifestations and prognostic factors of anti-NMDAR encephalitis with disturbance of consciousness.

METHODS

In this retrospective study, the clinical features, treatment results, and long-term outcomes of anti-NMDAR encephalitis patients with disturbance of consciousness were analyzed, and multivariate logistic regression was used to analyze the factors affecting their prognosis.

RESULTS

In the group with disturbance of consciousness, the incidences of seizures, involuntary movements, pulmonary infection, mechanical ventilation, intensive care unit (ICU) admission, neutrophil-lymphocyte ratio (NLR), abnormal cerebrospinal fluid index, plasma exchange, and immunosuppressive therapy were higher than those in the group without disturbance of consciousness (all P<0.05). During the follow-up period (median: 36 months, range: 12-78 months), the modified Rankin scale (mRS) score, the maximum mRS score during hospitalization, the mRS score at discharge, and the mRS score at 12 months after discharge were higher in the disturbance of consciousness group (all P < 0.001). However, there was no significant difference in long-term outcomes and recurrence between the two groups. Multivariate logistic regression analysis showed that mechanical ventilation, elevated IgG index, and delayed immunotherapy were independent risk factors for poor outcomes in patients with anti-NMDAR encephalitis with disturbance of consciousness at 12 months (odds ratio: 22.591, 39.868, 1.195). The receiver operating characteristics (ROC) curve analysis showed that the area under the curve (AUC) of mechanical ventilation, elevated IgG index, and delayed immunotherapy was 0.971 (95% CI=0.934-1.000, P<0.001).

CONCLUSION

Mechanical ventilation, elevated IgG index, and delayed immunotherapy may be the influencing factors of poor prognosis of anti-NMDAR encephalitis patients with disturbance of consciousness. Although their condition is relatively serious, most patients with anti-NMDAR encephalitis with disturbance of consciousness will achieve favorable long-term outcomes after long-term treatment.

摘要

目的

意识障碍在重症抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎患者中很常见。然而,对此了解甚少。本研究旨在分析伴有意识障碍的抗NMDAR脑炎的临床表现及预后因素。

方法

在这项回顾性研究中,分析了伴有意识障碍的抗NMDAR脑炎患者的临床特征、治疗结果及长期预后,并采用多因素逻辑回归分析影响其预后的因素。

结果

在意识障碍组中,癫痫发作、不自主运动、肺部感染、机械通气、入住重症监护病房(ICU)、中性粒细胞与淋巴细胞比值(NLR)、脑脊液指标异常、血浆置换及免疫抑制治疗的发生率均高于无意识障碍组(均P<0.05)。随访期间(中位数:36个月,范围:12 - 78个月),意识障碍组的改良Rankin量表(mRS)评分、住院期间最高mRS评分、出院时mRS评分及出院后12个月mRS评分均更高(均P < 0.001)。然而,两组的长期预后及复发情况无显著差异。多因素逻辑回归分析显示,机械通气、IgG指数升高及免疫治疗延迟是伴有意识障碍的抗NMDAR脑炎患者12个月时预后不良的独立危险因素(比值比:22.591、39.868、1.195)。受试者工作特征(ROC)曲线分析显示,机械通气、IgG指数升高及免疫治疗延迟的曲线下面积(AUC)为0.971(95%CI = 0.934 - 1.000,P<0.001)。

结论

机械通气、IgG指数升高及免疫治疗延迟可能是伴有意识障碍的抗NMDAR脑炎患者预后不良的影响因素。虽然其病情相对严重,但大多数伴有意识障碍的抗NMDAR脑炎患者经长期治疗后可获得良好的长期预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/10277025/911fa2c32489/PROM-14-181-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/10277025/00be24c5de21/PROM-14-181-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/10277025/911fa2c32489/PROM-14-181-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/10277025/00be24c5de21/PROM-14-181-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9189/10277025/911fa2c32489/PROM-14-181-g0002.jpg

相似文献

1
Risk Factors and Prognosis in Anti-NMDA Receptor Encephalitis Patients with Disturbance of Consciousness.伴有意识障碍的抗N-甲基-D-天冬氨酸受体脑炎患者的危险因素及预后
Patient Relat Outcome Meas. 2023 Jun 14;14:181-192. doi: 10.2147/PROM.S411260. eCollection 2023.
2
The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.抗NMDAR脑炎的临床特征及预后取决于血脑屏障的完整性。
Mult Scler Relat Disord. 2021 Jan;47:102604. doi: 10.1016/j.msard.2020.102604. Epub 2020 Oct 27.
3
Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis.抗N-甲基-D-天冬氨酸受体脑炎患者自主神经功能障碍的临床研究
Front Neurol. 2021 Feb 5;12:609750. doi: 10.3389/fneur.2021.609750. eCollection 2021.
4
Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.影响抗 N-甲基-D-天冬氨酸受体脑炎患者预后和复发的因素。
Mult Scler Relat Disord. 2023 Jun;74:104697. doi: 10.1016/j.msard.2023.104697. Epub 2023 Apr 3.
5
[Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].[35例重症抗N-甲基-D-天冬氨酸受体脑炎的免疫治疗策略]
Zhonghua Yi Xue Za Zhi. 2016 Apr 5;96(13):1035-9. doi: 10.3760/cma.j.issn.0376-2491.2016.13.011.
6
Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.抗 N-甲基-D-天冬氨酸受体脑炎患者的临床特征和预后。
Neurocrit Care. 2018 Oct;29(2):264-272. doi: 10.1007/s12028-018-0536-6.
7
Clinical characteristics of antiNmethylaspartate receptor encephalitis in children.儿童抗N-甲基-D-天冬氨酸受体脑炎的临床特征
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jan 28;45(1):47-54. doi: 10.11817/j.issn.1672-7347.2020.180761.
8
Analysis of Risk Factors for a Poor Prognosis in Patients with Anti--Methyl-D-Aspartate Receptor Encephalitis and Construction of a Prognostic Composite Score.抗N-甲基-D-天冬氨酸受体脑炎患者预后不良的危险因素分析及预后综合评分的构建
J Clin Neurol. 2020 Jul;16(3):438-447. doi: 10.3988/jcn.2020.16.3.438.
9
[Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].71例儿童抗N-甲基-D-天冬氨酸受体脑炎临床分析
Zhonghua Er Ke Za Zhi. 2019 Feb 2;57(2):125-130. doi: 10.3760/cma.j.issn.0578-1310.2019.02.012.
10
Risk Factors and Prognosis in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Requiring Prolonged Mechanical Ventilation.需要长期机械通气的抗N-甲基-D-天冬氨酸受体脑炎患者的危险因素及预后
Front Neurol. 2022 Feb 9;13:814673. doi: 10.3389/fneur.2022.814673. eCollection 2022.

引用本文的文献

1
A pediatric case of anti-GABAR encephalitis: case report and literature review.一例小儿抗GABAR脑炎病例报告及文献复习
Front Pediatr. 2025 Aug 25;13:1563323. doi: 10.3389/fped.2025.1563323. eCollection 2025.

本文引用的文献

1
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.颈部淋巴结和卵巢畸胎瘤作为 NMDA 受体抗体脑炎的生发中心。
Brain. 2022 Aug 27;145(8):2742-2754. doi: 10.1093/brain/awac088.
2
Immunotherapy in autoimmune encephalitis.自身免疫性脑炎的免疫治疗。
Curr Opin Neurol. 2022 Jun 1;35(3):399-414. doi: 10.1097/WCO.0000000000001048.
3
Risk Factors and Prognosis in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Requiring Prolonged Mechanical Ventilation.需要长期机械通气的抗N-甲基-D-天冬氨酸受体脑炎患者的危险因素及预后
Front Neurol. 2022 Feb 9;13:814673. doi: 10.3389/fneur.2022.814673. eCollection 2022.
4
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.免疫治疗 NMDA 受体抗体脑炎的使用和安全性:一项荟萃分析。
JAMA Neurol. 2021 Nov 1;78(11):1333-1344. doi: 10.1001/jamaneurol.2021.3188.
5
Characteristics and Prognosis of Autoimmune Encephalitis in the East of China: A Multi-Center Study.中国东部自身免疫性脑炎的特征与预后:一项多中心研究
Front Neurol. 2021 May 31;12:642078. doi: 10.3389/fneur.2021.642078. eCollection 2021.
6
The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.抗NMDAR脑炎的临床特征及预后取决于血脑屏障的完整性。
Mult Scler Relat Disord. 2021 Jan;47:102604. doi: 10.1016/j.msard.2020.102604. Epub 2020 Oct 27.
7
Analysis of Risk Factors for a Poor Prognosis in Patients with Anti--Methyl-D-Aspartate Receptor Encephalitis and Construction of a Prognostic Composite Score.抗N-甲基-D-天冬氨酸受体脑炎患者预后不良的危险因素分析及预后综合评分的构建
J Clin Neurol. 2020 Jul;16(3):438-447. doi: 10.3988/jcn.2020.16.3.438.
8
Neurocritical care for Anti-NMDA receptor encephalitis.抗 N- 甲基-D- 天冬氨酸受体脑炎的神经重症监护
Biomed J. 2020 Jun;43(3):251-258. doi: 10.1016/j.bj.2020.04.002. Epub 2020 Apr 21.
9
NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites.NMDAR 变构调节剂:多种化学型作用于多个结合位点。
Curr Top Med Chem. 2019;19(24):2239-2253. doi: 10.2174/1568026619666191011095341.
10
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models.神经科医生和精神科医生对抗 NMDA 受体脑炎的最新认识:发病机制和模型。
Lancet Neurol. 2019 Nov;18(11):1045-1057. doi: 10.1016/S1474-4422(19)30244-3. Epub 2019 Jul 17.